The Comparison Between Computed Tomography and Colonoscope in Detecting Colorectal Tumors in Patients With FIT+
NCT06165328
Summary
Colonoscopy is the mainstay modality of choice in colorectal cancer screening worldwide. However, the rate of colonoscopy for colorectal cancer screening is very low (approximately 5-10%) because of the limited local medical resources (such as endoscopists and regional endoscope). This observational diagnostic test study aims to compare the diagnostic yield of routine computed tomography and colonoscopy in detecting colorectal tumors in patients at risk of colorectal cancer (aged more than 50 years and FIT+). The main question\[s\] it aims to answer are: 1. To compare the diagnostic yield between the routine computed tomography and colonoscopy. 2. To compare the procedure-related adverse events between the routine computed tomography and colonoscopy.
Eligibility
Inclusion Criteria: 1. Fit test + 2. Normal platelet count and normal result of PT, PTT Exclusion Criteria: 1. pregnancy or lactation 2. uncontrolled Diabetes Mellitus, hypertension, asthma, congestive heart failure 3. recent coronary artery disease within 3 months 4. eGFR lesser than 30 mL/min/1.73m2 5. hemophilia or uncontrolled or uncorrected coagulopathy
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06165328